Human interleukin 5 (II.-5) plays an important role in proliferation and differentiation of human eosinophils. We report the isolation of cDNA clones from cDNA libraries of human eosinophils by using murine II.-5 receptor c~ chain cDNA as a probe. Analysis of the predicted amino acid sequence indicated that the human IL-5 receptor has 'o70% amino acid sequence homology with the murine IL-5 receptor and retains features common to the cytokine receptor superfamily. One cDNA clone encodes a glycoprotein of 420 amino acids (Mr 47,670) with an NH2-terminal hydrophobic region (20 amino acids), a glycosylated extracellular domain (324 amino adds), a transmembrane domain (21 amino acids), and a cytoplasmic domain (55 amino acids). Another cDNA encodes only the extracellular domain of this receptor molecule. Other cDNA clones encode molecules having diversified cytoplasmic domains. COS7 cells transfected with the eDNA expressed a *60-kD protein and bound Ib5 with a single class of affinity (Kd --250-590 pM). The Ka values were similar to that observed in normal human eosinophils. In contrast to the murine 60-kD oe chain, which binds IL-5 with low affinity (Ka = --10 riM), the human oe chain homologue can bind II.,5 with much higher affinity by itself. RNA blot analysis of human cells demonstrated two transcripts (*5.3 and 1.4 kb). Both of them were expressed in normal human eosinophils and in erythroleukemic cell line TF-1, which responds to IL-5. The human IL-5 receptor characterized in this paper is essential for signal transduction, because expression of this molecule in murine IL-3-dependent cell line FDC-P1 allowed these cells to proliferate in response to IL-5.
Human interleukin 5 (II.-5) plays an important role in proliferation and differentiation of human eosinophils. We report the isolation of cDNA clones from cDNA libraries of human eosinophils by using murine II.-5 receptor c~ chain cDNA as a probe. Analysis of the predicted amino acid sequence indicated that the human IL-5 receptor has 'o70% amino acid sequence homology with the murine IL-5 receptor and retains features common to the cytokine receptor superfamily. One cDNA clone encodes a glycoprotein of 420 amino acids (Mr 47,670) with an NH2-terminal hydrophobic region (20 amino acids), a glycosylated extracellular domain (324 amino adds), a transmembrane domain (21 amino acids), and a cytoplasmic domain (55 amino acids). Another cDNA encodes only the extracellular domain of this receptor molecule. Other cDNA clones encode molecules having diversified cytoplasmic domains. COS7 cells transfected with the eDNA expressed a *60-kD protein and bound Ib5 with a single class of affinity (Kd --250-590 pM).
The Ka values were similar to that observed in normal human eosinophils. In contrast to the murine 60-kD oe chain, which binds IL-5 with low affinity (Ka = --10 riM), the human oe chain homologue can bind II.,5 with much higher affinity by itself. RNA blot analysis of human cells demonstrated two transcripts (*5.3 and 1.4 kb). Both of them were expressed in normal human eosinophils and in erythroleukemic cell line TF-1, which responds to IL-5. The human IL-5 receptor characterized in this paper is essential for signal transduction, because expression of this molecule in murine IL-3-dependent cell line FDC-P1 allowed these cells to proliferate in response to IL-5.
I
L-5 is a glycoprotein secreted by T cells and mast cells (1, 2), originally identified by its ability to stimulate proliferation and differentiation in vitro of murine activated B cells and CD5 § B cells, and to induce proliferation and differentiation of eosinophils from bone marrow proliferation (3) (4) (5) (6) (7) (8) (9) . In the human system, IL-5 also promotes proliferation and differentiation of eosinophils from bone marrow progenitors (10) (11) (12) . There are contradictory reports, however, describing the role of IL-5 on human B cells. It was reported that it induces maturation of human peripheral B cells stimulated with Staphylococcus aureus Cowan I into IgM-secreting cells (13) , and was also reported to be an IgA-enhancing factor (14) . However, it was also reported that human Ib5 (hII.,5) 1 does not show any activity on human B cells in a conventional B cell assay (15) .
To clarify the role of IL-5 in the human immune system and hematopoiesis, we and others attempted to explore the characteristics of hlI.-5R (16) (17) (18) (19) . It was reported that human eosinophils in peripheral blood and eosinophilic sublines from promyelocytic leukemia (Hb60) cells express a single class of high affinity binding sites for IL-5 with Kas of 170-330 and 10-50 pM, respectively (16, 18) . By cross-linking experiments, we detected a 55-60-kD protein on normal eosinophils (18) . Others reported 60-and 120-130-kD proteins in eosinophilic sublines from HL-60 and in an erythroleukemic cell line, TF-1 (16, 19) . We have shown from the series of binding and cross-linking studies that murine IL-5 (mlL-5) binds to mlL-SR with both high (Ka = "~150 pM) and low affinity (Ka --"~30 nM) and that at least two polypeptide chains comprise the functional mlbSR (20) . We recently isolated cDNA clones encoding the mllc5R ot chain (60 kD) that binds IL-5 with low affinity (21) . It is very suggestive that there is a significant homology between h-and mlL-SRs, because mlL-5 was shown to bind hlI~SR as efficiently as hlL-5, and they are ',~70% homologous in terms of amino acid sequences (13, 14) . Then, we tried to fish out a cDNA clone for hlL-5K by cross-species hybridization using mlL-5R c~ chain cDNA as a probe.
In this report, we describe the characterization of hlL-5R by isolating the cDNA clones for it. rhlL-5R expressed on COS7 cells showed similar binding properties and biochemical characteristics to those of the native receptor on human eosinophils. Analysis of the sequence of hlL-SK demonstrates that the hlL-5R is also a member of a cytokine receptor superfamily and contains three fibronectin type III (FBN III) modules (22) (23) (24) (25) (26) .
Materials and Methods
Reagents and Cell Lines. rmlL-5 and 3SS-methionine labeled mlL-5 were prepared according to procedures described previously (27) . rhlL-5 was purified using anti-IL-5 mAb NC17 (28) from the culture supernatant of Spodoptera frugiperda (Sf21) cells transfected with hlL-5 cDNA in baculovirus expression vector (unpublished results), rhlL-5 was labeled with l~SI using diiode-Bolton-Hunter reagent (4,000 Ci/mmol; DuPont-New England Nuclear, Boston, MA) as described (29) . rhlL-2 was a kind gift from Takeda Central Research Institute (Osaka, Japan). rhlb3, rhlb4, rhlL-6, recombinant human granulocyte colony-stimulating factor (G-CSF), and human recombinant granulocyte/macrophage colony-stimulating factor (GM-CSF) were from Japan Roche Research Institute (Kamakura, Japan), Ono Pharmaceutical Co., Ltd. (Osaka, Japan), Dr. T. Hirano (Osaka University, Osaka, Japan), Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan), and Sandoz Pharmaceutical Co., Ltd. (Basel, Switzerland), respectively. Human erythroleukemic cell line TF-1 (30) was a generous gift from Dr. T. Kitamura (DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA). Human eosinophilic leukemia cell line Eob3 and human adult T cell leukemia cell line ATL-2 were kindly provided from Drs. M. Hirashima and N. Asou (Kumamoto University Medical School, Kumamoto, Japan), respectively. All human cell lines were maintained in RPMI 1640 containing 10% FCS, 5 x 10 -5 M 2-ME, 100 U/ml penicillin, and 100 #g/ml streptomycin. A mlL-3-dependent cell line, FDC-P1, was maintained in the same medium in the presence of 10 U/ml of mlL-3.
RNA Isolation and Construction of cDNA Library. Human eosinophils were isolated from peripheral blood of healthy volunteers or from a patient with idiopathic eosinophilic syndrome. In brief, eosinophils were purified from the 0.5% polyvinylpyrrolidonesedimented erythrocyte/leukocyte fraction of peripheral blood through discontinuous layers (density, 1.080-1.100) of Percoll (Pharmacia LKB Biotechnology, Uppsala, Sweden) as described (18) . Total RNAs were prepared from eosinophils by the guanidium isothiocyanate/CsTFA method (31) , and poly(A) + RNA was selected by oligo(dT)-cellulose column chromatography, cDNA library from eosinophils from healthy volunteers was constructed in the vector with chicken ~-actin promoter, pAGS-3 (32). Double-stranded cDNA was synthesized using random primer according to the method by Gubler and Hoffman (33) using 5 /xg of poly(A) § RNA with the manufacturer's kit (Bethesda Research Laboratories, Bethesda, MD). The blunt-end cDNA was modified with BstXI linkers, size fractionated by 5-20% potassium acetate gradient centrifugation, and cDNA '~>1.0 kb was cloned into pAGS-3 as described (34) . Transformation ofEscherichia coli strain MC1061 was carried out by electroporation (2.5 kV, 25/~F, 200 f]) in 0.2-cm cuvettes using Gene Pulser apparatus (Bio-Rad Laboratories, Richmond, CA) (35) . Approximately 106 independent colonies were obtained by transforming MC1061 with pAGS-3 cDNA library, cDNA library from a patient with eosinophilia was constructed in the kgtl0 vector using 5 #g of poly(A) + RNA. 1.6 x 106 independent plaques were obtained.
Screening ofcDNA Libraries. Screening of the pAGS-3 library was performed using a 32p-labeled 1.2-kb HindllI-PstI fragment of mll.,5R cr chain cDNA clone plL-SR.8 (21) as a hybridization probe under low-stringency conditions. Colonies were blotted on nitrocellulose membranes (Millipore, Bedford, MA) and hybridization was performed at 65~ with 10x Denhart's solution, 6 x SSC, 0.5% SDS, 100 #g/ml of denatured salmon sperm DNA for 20 h, and washed with lx SSC, 0.1% SDS at 45~ (36) . Subsequently, a 1.0-kb XhoI fragment of positive clone (phSR.1, see Results) was used as a probe to isolate other clones from the hgtl0 library. Plaques were transferred to nylon membranes (Colony/ Plaque Screen; DuPont-New England Nuclear) and hybridization was performed according to the manufacturer's recommendation and washed with 2x SSC, 1% SDS at 65~ All hybridization probes were labeled with a-[3~p]dCTP by random primer labeling method using a kit from Pharmacia LKB Biotechnology.
DNA Sequencing. The cDNA inserts of clones, ph5R.1, hhSR.12, kh5R.27, and kh5R.25, were sequenced by the dideoxy chain termination method (37) using the modified T7 polymerase (Sequenase; U.S. Biochemical Corp., Cleveland, OH) after being subcloned into pBluescript KS(-) vector (Stratagene, La Jolla, CA).
Expression of the hlL5R cDNA. A transient expression system with COS7 cells was used together with the mammalian expression vector pCAGGS (38) (generously provided by Dr. J.-I. Miyazaki, University of Tokyo, Tokyo, Japan), which is a derivative of pAGS-3 (32) . An EcoRI fragment of either kh5R.12 or Xh5R.27 clones was inserted into a unique EcoKI site of pCAGGS, resulting in pCAGGS-hSK.12 or pCAGGS-h5R.27. Each plasmid DNA was transfected into COS7 cells by electroporation as described (39) . COS7 transfectants were cultured in DME containing 10% FCS, 100 U/ml penicillin, and 100 #g/ml streptomycin. After a 3-d culture, cells were harvested with the treatment of PBS containing 0.5 mM EDTA and subjected to further analysis.
For FDC-P1 cells, pSV2-neo and pCAGGS-5R.12 (1 and 20/~g, respectively) were cotransfected by electroporation at 1.5 kV and 25/zF. Stable transfectants were selected with 400 #g/ml of G418 (geneticin; Sigma Chemical Co., St. Louis, MO).
Binding Assay and Scatchard Analysis. For competition experiments, COS7 transfectants were harvested and suspended at 4 x 105 cells per 100 #1 of the binding medium (RPMI 1640, 25 mM Hepes, pH 7.2, 0.1% BSA), and incubated with 500 pM nSI-hlL-5 (2.0 • 1013 cpm/mmol) in the presence of >1,000-fold molar excess of unlabeled various cytokines at 4~ for 1 h (18, 29) . For binding assay, COS7 transfectants were resuspended at 5-10 x 104 per 100 #1 of the binding medium, and incubated with increasing concentrations of 12SI-hlL-5 or 3sS-labeled mlL-5 (2.3 x 1015 cpm/mmol) at 4~ for 1 h. Specific binding was defined as the difference between total binding and nonspecific binding obtained in the presence of a 250-fold molar excess of unlabeled IL-5. The Kd was calculated by Scatchard plot analysis (40) of the binding data.
Chemical Cross-linking. COS7 transfectants were cultured for 2 mM PMSF, 10 ~M pepstatin, 10 /~M leupeptin, 2 mM O-phenanthroline, and aprotinin at 200 KIU/ml) as described (29) . The detergent extraction mixture was subjected to SDS-PAGE with 7.5% polyacrylamide under nonreducing conditions, and then analyzed by a Bio-Analyzer (model 100; fuji Photo Film, Tokyo, Japan).
RNA Blot Analysis. Poly(A) + RNA (6 /~g) prepared from human eosinophils in peripheral blood, TF-1, EoL-3, ATL-2, Raft, and U-937 were subjected to electrophoresis through 1% agarose gel containing 2.2 M formaldehyde as described (36) , and transferred to a nylon membrane (Gene Screen; DuPont-New England Nuclear). Hybridization was carried out according to manufacturer's recommendation using a 32p-labeled full-length EcoRI cDNA insert of ~hSR.12 as a probe.
Proliferation Assay. FDC-P1 cells and FDC-P1 transfectants were inoculated in a 96-well microtiter plate at a concentration of 104/0.2 ml/well with various concentrations of hlL-5. They were pulse labeled with [3H]thymidine (0.2 #Ci per well) during the last 6 h of a 48-h culture period, and incorporated [3H]thymidine was measured by a liquid scintillation counter.
Results
Isolation and Characterization of hlL 5R cDNA Clones. Two cDNA libraries of human eosinophils prepared from normal volunteers and from a patient with eosinophilia were used to isolate hlL-5R cDNA clones. At first, screening was performed by cross-species hybridization using mlL-5R a chain cDNA clone as a probe at low-stringent conditions. One clone, ph5R.1, that has a 931-bp insert was obtained from pAGS-3 library of normal human eosinophils (Fig. 1 A) . This clone did not cover the entire coding region of hlL-5R. Then, three clones (~5R.12, khSR.27, and h, hSR.25) were isolated from ~gtl0 library of eosinophils from an eosinophilia patient using ph5R.1 as a probe by plaque hybridization, cDNA inserts from ~5hR.12, h.hSR.27, and ~h5R.25 were found to be 2,006, 2,024, and 1,405 bp, respectively ( Fig. 1 A) . Both ~hSR.12 and ~,hSR. 27 have the open reading frame (ORF) that encodes a protein equivalent to mlL-5R o~ chain in molecular size. Because the nudeotide sequence of the ORF of MaSR.12 clone (1,260 bp) was the best match for the mlL-5R a chain (21) in terms of constitution, this clone was analyzed most in this paper. The nucleotide sequence of hlL-SR from Xh5R.12 is shown in Fig. 1 B. A 3' untranslated region (3' UTR) of 685 nucleotides extends without the polyadenylation signal AATAAA. The ORF of khSR.12 encodes a mature protein of 400 amino acids with a calculated molecular weight of 45,556 synthesized with a 20-amino acid signal sequence. The site of signal sequence was in agreement with the sites based on the predictive system of yon Heijne (41) . The mature hlL-5R protein of 400 amino acids can be divided into several regions according to a prediction by the Doolittle hydropathy plot (42) ; the extracellular domain was comprised of 324 amino acids, transmembrane domain was comprised of 21 amino acids, and cytoplasmic domain was comprised of 55 amino acids. The extracellular domain contains two pairs of cysteines and a "WSxWS" box, as seen in a cytokine receptor superfamily (22) (23) (24) . Six N-linked glycosylation sites were seen.
There was a 57-bp insert in the cytoplasmic domain of the phSR.1 clone, generating a 19-amino acid insertion in this domain (Fig. 1 C) . The 3' UTR ofph5R.1 has 511 nucleotides, which is the same as the 3' UTR of ~h5R.12, except for one base: the 1,714th T in Xh5R.12 is changed into C in ph51k.1. The nucleotide sequence of the ~h5R.27 clone was identical to that of ~h5R.12 in extracellular domain and transmembrane domain, except a point mutation at position 385 that changed G to A resulting in a change of Val to lie. ~h5R.27 was distinguished from Xh5R.12 by having a totally different sequence of 737 bp, which starts from nucleotide 1185 (Fig. 1 D) . Consequently, the cytoplasmic domain of ~hSR.27 is 24 amino acids shorter than that of ~h5R.12.
hah5R.25 clone encodes an hlL-SR that has neither a transmembrane domain nor a cytoplasmic domain. The site indicated by the open arrowhead (Fig. 1, A and B) is the predicted site of splicing that is followed by an unique sequence resulting in the addition of two amino acids before termination (Fig.  1 E) . This predicted site of splicing is very similar to that observed in pIL.5R.2 encoding soluble mlL-SR (21) . The sequence upstream from this arrow is identical to that of XhSR.27. Thus, ~kh5R.25 may code for a soluble form of hlL-5R. This predicted mature protein is 313 amino acids in length with a calculated Mr of 35, 607 .
Three Units of a FBN III Module in the Extracellular Domain and the Proline Cluster Region in the Cytoplasmic Domain.
Alignment of the predicted amino acid sequence of the hlL-5R (~kh5R.12) with that of the mlL-SR c~ chain (21) exhibited a high degree of homology (69% homology) throughout the length of the molecules (Fig. 2) . In addition, all seven of the extracellular and four of the transmembrane and intracellular cysteine residues are conserved in the h-and mlb5R molecules. Four of the six potential N-glycosylation sites are conserved in the mlL-SR oL chain (Asn35, Asn131, Ash216, and Ash244) (data not shown). A part of the extracellular domain of hlL-5R (126-344 amino acid residues) contains two pairs of cysteine residues and the "WSxWS" box ( Fig.  2 A) . The hlI:5R, therefore, belongs to a cytokine receptor superfamily (22) (23) (24) , as in the mlL-5R o~ chain (21) . We examined the extraceUular domain in view of sequence and structural pattern matching as others did (25, 26, (43) (44) (45) (46) . We detected FBN III motifs not only in domains that belong to the cytokine receptor superfamily, but also in the NH2-terminal domain (21-125 amino acid residues) (Fig. 2 A) . There were conserved motifs such as a pair ofproline residues that precede an amphiphilic/8 strand and a conserved tryptophan. In the cytoplasmic domain, the proline cluster region (21) (from Leu371 to Asp384) is well conserved in the h-and mlL-5R molecules (Fig. 2 B) .
Binding and Biochemical Characteristic of hll_,5Rs. We examined the binding specificity of the protein coded by the cDNA clones, by expressing the cDNA in COS7 cells. We inserted Xh5R.12 and XhSR.27 cDNA fragments into the expression wctor pCAGGS (38) , resulting in pCAGGS-h5R.12 and pCAGGS-hSR.27, respectively. These two recombinant clones were transfected into COS7 cells. The binding of 2251-hlL-5 to the COS7 cells transfected with pCAGGS-h5R.12 was specific for IL-5. Other human cytokines such as IL-2, (Fig. 5 A) . In the case of the cross-linking experiment with 12SI-hlL-5, whose molecular mass is "~30 kD, the molecular mass of the major band was '~85 kD. The expected molecular mass was ~55-60 kD, as shown in Fig. 5 hlL-5R calculated from the predicted amino acid sequence is 45,556, and it is likely that the higher molecular weight observed for the expressed receptor molecule is due to glycosylation or other posttranslational modifications. The estimated molecular weight of hIL-51L derived from the cDNA cloned in this study was very similar to that of hIL-5R of normal eosinophils in human peripheral blood (18). Fig. 6, lanes I and  2) . These bands were absent in the RNA prepared from eosinophilic leukemia EoI,3, adult T cell leukemia ATb2, Burkitt lymphoma cell line Raft, and histiocytic lymphoma cell line U-937 (Fig. 6, lanes 3-6) . 
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Expression of the hlL5R Transcripts. Expression of the hlL-
Discussion
In this report, we described the isolation of hlL-5R cDNA from human eosinophil libraries by cross-species hybridization using the mlL-5R ot chain cDNA that encodes IL-5 binding protein of mlI~5R (21) . The predicted mature hid 5R has '~70% homology with that of its murine counterpart. It has conserved two pairs of cysteines and a "WSxWS" box that are the characteristics of the cytokine receptor superfamily (22) (23) (24) . Recently, it has been reported that the sequence and structural pattern of the FBN III module are conserved in a cytokine receptor superfamily (25, 26, (43) (44) (45) (46) . We found not only domains with characteristics of a cytokine receptor superfamily, but also the NH2-terminal domain of IL-5R (21-125 and 18-122 amino acid residues for hlL-SR and mlL-SR, respectively) has the sequence and structural pattern of FBN III (Fig. 2 A) . The role of the FBN III module in this cytokine receptor superfamily is discussed in two ways. One possibility is that the region containing the FBN III module contributes to the interaction of the receptors with ligands or with other components of the receptor complex (26) . In fact, mlL-SR consists of two chains, ot and/~ (47) (48) (49) . It might simply imply that the ligand binding moiety of a cytokine receptor superfamily consisting of the V-shaped crevice between linked FBN III modules is evolved from a primitive adhesion molecule (25) . The other hypothesis is that it is involved in cell adhesion. Fukunaga et al. (43, 44) discussed that the similarity of the extracellular domain of the G-CSF receptor with contactin may explain the role of this region in the communication of neutrophilic progenitor cells with stromal cells. Of course, these two possibilities do not exclude each other. These FBN III modules of a cytokine receptor superfamily may be involved in cell-to-cell communication and ligand binding at the same time (45, 46) .
The cytoplasmic domain of this hlL-5R does not have any kinds of protein kinase domain (50) , or serine-rich region observed in other cytokine receptors (39, (43) (44) (45) (46) (51) (52) (53) (54) (55) (56) (57) . However, the proline cluster region (from Leu371 to Asp384) that is shared among receptors for growth hormone (58, 59) , prolactin (60, 61) , and GM-CSF (24) is conserved as in the mlL-5R c~ chain (21) . This fact suggests the existence of a certain common interaction mechanism among these receptors. The existence of a second chain of hlL-SR is also suggested because the cytoplasmic domain of this ligand binding moiety of the hlL-5R, is too short to transduce signals. The cytoplasmic region of hlL-SR also has similarity with fl-spectrin as suggested (62) . It is possible that the IL-5R complex may be anchored in the F-actin-containing structure.
Analysis of rhlL-5Rs confirmed that their ligand binding characteristics and their features in chemical cross-linking patterns are very similar to those of their naturally occurring molecules. This is quite contradictory to the constitution of mlL-SRs in view of the role of a second chain in the formation of a high affinity receptor. A functional mlL-5R consists of an ol and fl chain (47) (48) (49) . While the 60-kD c~ chain has IL-5 binding moiety, the 130-kD fl chain does not bind IL-5 by itself. The ol chain itself binds IL-5 with low affinity. The c~/fl heterodimer forms a high affinity mlL-5R. The "~60-kD protein encoded by the cloned hlL-5R cDNA, which is the counterpart of the mlL-5R c~ chain, bound IIr with an affinity almost similar to native hlb5R-bearing cells. In terms of affinity, there are significant differences among reports published, including ours. Plaetinck et al. (16) reported a single class of binding sites with a Ka of 22 pM on human eosinophilic subline from HLo60. Chihara et al. (17) reported two types of hlL-SRs; one is for hypodense eosinophils with a Kd of 518 pM, and the other is for normodense cells with a Kd of 2.6 riM. Kitamura et al. (19) also reported two types of hlL-5R on TF-1 cells at the basal level; one is high affinity sites (Ka = 120 pM), and the other is low affinity sites (Ka = 2 riM). On normal human eosinophils, we reported a single class of high affinity receptors with Kds of 170-330 pM. We cells. It is still not clear whether hlL-5R on normal eosinophils consists of two chains as in the murine system.
In the mI1.5R system, the B chain is proved to be I1.3R homologue AIC2B (48, 49) , and is probably shared with GM-CSF receptor (GM-CSFR) (63) . We can expect the hll=5R to also use AIC2B homologue KH97 (the/~ chain of human GM-CSFR.) (39, 57) for the construction of a high affinity receptor. In light of these studies, our results can be interpreted in two different ways concerning the contribution of B chain to the formation of the high affinity hI1.5R. The first possibility is that the hI1.5R does not use the/~ chain of human GM-CSFR. It may not have a second chain as its constituent or may use a different protein. However, this is unlikely because of the short cytoplasmic domain and conserved amino acid sequences of hlb5R ot chain with mouse homologue. The second possibility is that hI1.5R also uses the B chain of GM-CSFR, but it is engaged in the hlL-5R system in a way that does not contribute to its affinity as much as in the murine system. We favor the latter possibility, because I1.3, I1-5, and GM-CSF seem to work coordinately in hematopoiesis. Expression of human GM-CSFR in mufine FDC-P1 ceils allowed these cells to proliferate in response to human GM-CSF, though only low affinity receptors were expressed (64). Kitamura et al. (63) reported that the expression of the ot chain of human GM-CSFR together with AIC2B (/3 chain ofmI1.5R) in CTLL-2 (IL-2-dependent mouse T cell line) cells conferred a growth response to human GM-CSF on these cells. We observed similar phenomena in the case of I1.5, as shown in Fig. 7 . In this case, the hll_,5R ot chain probably forms a heterodimer with the B chain of mlL-5R like the GM-CSFR c~ chain. We are in the process of checking the possibility that the B chain of human GM-CSFR is shared with the hlb5R by cotransfecting appropriate cells with cDNAs of hlL-SR and KH97 (57), the B chain of human GM-CSFR..
We detected two classes of mRNAs (•5.3 and ~1.4 kb) encoding hlbSR. 1.4-kb transcripts may code for soluble form of hI1.5R. In addition to membrane-bound receptor forms, we isolated a done, ~a5R.25, that encodes a soluble form of the hI1.5R. The soluble form has been also identified in the mouse (21, 62 ) and a common splicing mechanism seems to be used in two species. The biochemical characterization and the examination of the expression of this molecule in various tissues at different stages may shed light on its biological role. It was clear that XhSR.27-type mRNA are not abundant, because this mRNA type could not be detected in normal eosinophils by PCR technique (data not shown). It is possible that the )xh5R.27-type message is restricted to the eosinophilia patient from whom we constructed the library. This may imply a change in the genome or in the processing of the messages.
The expression of this hlL-5R gene is restricted in eosinophils or related cell lines as shown in this paper or in our previous paper (18) , In the mouse, however, mlb5 selectively supports the growth of CD5 + B cells besides eosinophils in vivo (4) . Indeed, Ib5R is expressed in the CD5 + B cell subpopulation, and this B cell subpopulation is more responsive than conventional B cells are to I1.-5 (65, 66) . We have to wait before we draw any conclusions until an extensive survey in the detection of the hI1.5R message at various developmental and activated stages of human B cells is done. The molecular cloning of hI1.SR cDNA also enabled us to study the possible role of the IL-SR in human disease with an increased level of eosinophils.
